Mr. Quang Pham
Chairman and CEO
Quang Pham is a biopharmaceutical entrepreneur with over 20 years of experience in founding, financing, and growing companies. He has served as our Chief Executive Officer and Chairman since he founded Espero in 2014.
Mr. Jeff Cole
President and CFO
Mr. Cole has over 23 years of experience in finance, business development and commercial operations at public and privately held companies. This includes more than 15 years in the pharmaceutical industry holding various senior executive roles at companies such as Valeant Pharmaceuticals (NYSE: VRX), Solco Healthcare US, MarcasUSA, and Legacy Pharmaceuticals. His positions at Valeant included CFO North America, VP of Corporate Development, and General Manager of the US Specialty Division.
Mr. Wayne Yetter
Director and Senior Advisor
Mr. Yetter is a pharmaceutical industry veteran, board director and advisor. He has held leadership positions at global companies, including President and CEO of Novartis Pharmaceuticals and founding CEO of Astra-Merck (now AstraZeneca). He has also held senior roles at IMS Health, Odyssey Pharmaceuticals, and Verispan.
Mr. Stefan Roever
Mr. Roever has a broad entrepreneurial, software, and finance background. He is CEO and founder of Genia Technologies, a next generation DNA sequencing company based in Mountain View, CA. Genia was sold to Roche in June 2014 for $350 million. He’s also founder and Chairman of gBox, a video monetization and distribution platform.
Dr. Larry Hsu, Ph.D.
Dr. Hsu is currently Chairman & CEO of Lifemax Healthcare International Corporation and general partner at Hercules BioVenture Partners as well as Capital TEN II Fund. He co-founded Impax Pharmaceuticals, Inc., a drug-delivery technology-based pharmaceutical company with headquarters located in the San Francisco Bay Area.
Mr. Henrik Hesse
Currently Mr. Hesse serves as Executive Director at Pohl-Boskamp, managing Legal, Finance, and R&D. He also acts as an honorary judge for labor law with the court system in Germany. He started his career as an attorney with a law firm, prior to joining Pohl-Boskamp as General Counsel.
Dr. Peter G. Milner
Dr. Milner was a co-founder and Executive Chairman of Armetheon, Inc. He has been CEO of Heart Metabolics Limited UK (now HMBL) since 2011 and was also CEO of Heart Metabolics Limited Ireland from 2014 to 2015.